Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia
Study Details
Study Description
Brief Summary
This study aims to determine the effectiveness of game-based biofeedback application via surface electromyography in patients with post-stroke dysphagia. The same treatment interventions will be applied with and without biofeedback, and thus the contribution of adding biofeedback to the treatment will be determined.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: EMG-Biofeedback Mendelsohn maneuver and effortful swallow exercise will be applied through game-based emg-biofeedback to patients with post-stroke dysphagia. |
Device: With EMG-Biofeedback
Mendelsohn maneuver and effortful swallow exercise to be applied with game-based emg-biofeedback for 30 minutes a day for 15 sessions.
Behavioral: Usual Care
Patient and family education will be provided by the investigator. In addition, each patient will be evaluated and oral motor exercises and thermal tactile stimulation will be given to each patient when necessary.
|
| Active Comparator: Classic Therapy Mendelsohn maneuver and effortful swallow exercise with only verbal feedback will be applied to patients with post-stroke dysphagia. |
Behavioral: Without EMG-Biofeedback
Mendelsohn maneuver and effortful swallowing exercise will be applied in 15 sessions of 30 minutes a day with only verbal feedback.
Behavioral: Usual Care
Patient and family education will be provided by the investigator. In addition, each patient will be evaluated and oral motor exercises and thermal tactile stimulation will be given to each patient when necessary.
|
Outcome Measures
Primary Outcome Measures
- Gugging Swallowing Screen (GUSS) [From baseline to the end of the treatment ( 3 week)]
It is used to determine the severity of dysphagia and the risk of aspiration in patients with acute stroke. It is evaluated out of 20 points. It recommends videofluoroscopy as an advanced examination for patients with a score of less than 20.
- Functional Oral Intake Scale (FOIS) [From baseline to the end of the treatment ( 3 week)]
7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.
- Penetration Aspiration Scale (PAS) [From baseline to the end of the treatment ( 3 week)]
Videofluoroscopic evaluation is performed. It is an 8-point scale. The higher the number, the greater the increase in penetration/aspiration. 1 means no penetration and no aspiration. 8 means there is aspiration and there is no patient response.
- Functional Dysphagia Scale (FDS) [From baseline to the end of the treatment ( 3 week)]
Videofluoroscopic evaluation is performed. It is a total of 100 points scale. A higher score indicates more severe dysphagia.
- Dysphagia Outcome and Severity Scale (DOSS) [From baseline to the end of the treatment ( 3 week)]
Videofluoroscopic evaluation is performed. It is a 7-point scale. A score of 6 and 7 represents normal swallowing, a score of 5 represents mild dysphagia, a score of 2 to 4 represents moderate dysphagia, and a score of 1 represents severe dysphagia.
- Dysphagia Handicap Index (DHI) [From baseline to the end of the treatment ( 3 week)]
Dysphagia Handicap Index (DHI) is a self-assessment questionnaire which consists of 25 statements to examine three aspects of dysphagia patients' quality of life (QoL): functional, physical, and emotional. The patient can get a maximum score of 100 points.A higher score indicates a more severe swallowing disorder.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
History of hemorrhagic or ischemic stroke longer than 3 months
-
Being over the age of eighteen
-
Level ≤ 6 on the Functional Oral Intake Scale (FOIS)
-
Post-stroke onset of swallowing complaints
-
Ability to communicate with the patient and carry out the given commands
-
Mini mental test evaluation of at least 20 points
-
Absence of concomitant serious systemic disease (unregulated hypertension, decompensated heart failure, malignancy, infection, pacemaker, epilepsy, etc.)
-
Detection of pathology in the oropharyngeal phase of swallowing in videofluoroscopic evaluation
-
Not taking any swallowing-related treatment in the last 3 months
Exclusion Criteria:
-
History of neoplastic disease and/or radiotherapy to the head and neck region
-
Having additional musculoskeletal disease or non-stroke neurologic disease that may cause swallowing disorders
-
Unable to communicate or carry out commands
-
Inability to maintain head-holding balance
-
Patients with severe pathology in bolus formation or delivery of the bolus to the pharynx during the oral swallowing phase
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Bülent Alyanak | Kocaeli | Turkey | 41001 |
Sponsors and Collaborators
- Kocaeli University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- E-68869993-000-1019202